Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

Masanori Abe; Noriaki Maruyama; Hiroko Suzuki; Yuki Fujii; Midori Ito; Yoshinori Yoshida; Kazuyoshi Okada; Masayoshi Soma

doi:10.1038/hr.2012.45

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2012.45 ◽

2012 ◽

Vol 35 (8) ◽

pp. 874-881 ◽

Cited By ~ 12

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Hiroko Suzuki ◽

Yuki Fujii ◽

Midori Ito ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.erratum2009_912 ◽

2009 ◽

Vol 16 (6) ◽

pp. 912-912

Author(s):

Yoh Miyashita ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2011.67 ◽

2011 ◽

Vol 34 (8) ◽

pp. 935-941 ◽

Cited By ~ 21

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Kazuyoshi Okada ◽

Shiro Matsumoto ◽

Koichi Matsumoto ◽

...

Keyword(s):

Angiotensin Receptor Blocker ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Type 2 Diabetic Patients ◽

Antioxidative Effects ◽

Type 2 Diabetic

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.497 ◽

2009 ◽

Vol 16 (5) ◽

pp. 621-626 ◽

Cited By ~ 40

Author(s):

Yoh Miyashita ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.1628 ◽

2009 ◽

Vol 16 (5) ◽

pp. 568-575 ◽

Cited By ~ 47

Author(s):

Hidehisa Sasaki ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Renal Function ◽

Arterial Stiffness ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Protective Effects ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

COMPARATIVE TRIAL OF ANGIOTENSIN RECEPTOR BLOCKER (ARB)-DIURETIC VERSUS ARB-CALCIUM CHANNEL BLOCKER COMBINATION THERAPY FOR HYPERTENSION UNCONTROLLED BY ARB MONOTHERAPY: THE KANAGAWA COMBINATION ANTIHYPERTENSIVE THERAPY (K-CAT) STUDY

Journal of Hypertension ◽

10.1097/00004872-201106001-01704 ◽

2011 ◽

Vol 29 ◽

pp. e562

Author(s):

J. Oshikawa ◽

Y. Toya ◽

J. Okabayashi ◽

S. Kobayashi ◽

T. Mikawa ◽

...

Keyword(s):

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Comparative Trial ◽

Receptor Blocker ◽

Angiotensin Receptor

Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients

Circulation Journal ◽

10.1253/circj.cj-15-0815 ◽

2016 ◽

Vol 80 (2) ◽

pp. 426-434 ◽

Cited By ~ 2

Author(s):

Norihisa Toh ◽

Katsuhisa Ishii ◽

Hajime Kihara ◽

Katsuomi Iwakura ◽

Hiroyuki Watanabe ◽

...

Keyword(s):

Calcium Channel ◽

Diastolic Function ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hypertensive Patients

Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2012.09.001 ◽

2012 ◽

Vol 6 (6) ◽

pp. 393-398 ◽

Cited By ~ 2

Author(s):

Johji Kato ◽

Naoto Yokota ◽

Noboru Tamaki ◽

Sumito Kariya ◽

Toshihiro Kita ◽

...

Keyword(s):

Blood Pressure ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor

Combination Angiotensin-Receptor Blocker (ARB)/Calcium Channel Blocker With HCTZ vs the Maximal Recommended Dose of an ARB With HCTZ in Patients With Stage 2 Hypertension: The Exforge As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXA

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2011.00492.x ◽

2011 ◽

Vol 13 (8) ◽

pp. 588-597 ◽

Cited By ~ 13

Author(s):

Richard F. Wright ◽

Daniel Duprez ◽

Das Purkayastha ◽

Rita Samuel ◽

Keith C. Ferdinand

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Systolic Hypertension ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Recommended Dose ◽

Angiotensin Receptor ◽

Losartan Treatment

Calcium Channel Blocker Azelnidipine Reduces Glucose Intolerance in Diabetic Mice via Different Mechanism Than Angiotensin Receptor Blocker Olmesartan

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.106.108894 ◽

2006 ◽

Vol 319 (3) ◽

pp. 1081-1087 ◽

Cited By ~ 25

Author(s):

Masarsu Iwai ◽

Huan-Sheng Li ◽

Rui Chen ◽

Tetsuya Shiuchi ◽

Lan Wu ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Glucose Intolerance ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Diabetic Mice ◽

Angiotensin Receptor

The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension

American Journal of Cardiovascular Drugs ◽

10.2165/11538850-000000000-00000 ◽

2010 ◽

Vol 10 (5) ◽

pp. 315-320 ◽

Cited By ~ 14

Author(s):

Steven G. Chrysant

Keyword(s):

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Angiotensin Receptor